Back to all Programs

Past Event

Related Materials

Past Event

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014

Pharmacokinetics of rifampicin, isoniazid and pyrazinamide in children on 2010 WHO/IUATLD guideline doses - H. McIlleron

A simultaneous population pharmacokinetic analysis in Malawian adults and children of rifampicin - A. Schipani

Pharmacokinetics of rifampin among pregnant women with tuberculosis and HIV co-infection - K. Dooley

Clinical Pharmacology Issues for Pediatric TB - Sharon Nachman, MD

The Critical Path to TB Drug Regimens: Advancing through a Multidisciplinary, Multipartner Approach - Klaus Romero, MD, MS

Drug-drug interactions between bedaquiline and the antiretrovirals nevirapine and lopinavir/ritonavir in patients - M. Pandie

Population pharmacokinetics and bacterial dynamics of sutezolid in patients with active tuberculosis - K.B. Larson

High dose rifampicin: a phase II trial comparing 10, 15 and 20 mg/kg rifampicin for two months - R. Aarnoutse

The inhibitory potential of TB drugs on ATP-binding cassette transporters MRP1- 5, P-gp, BCRP and BSEP - L. Te Brake

A quantitative and systems pharmacology approach to dose optimization in experimental tuberculosis: opportunities and experimental data needs - M. Lyons

A semi mechanistic pharmacokinetic-pharmacodynamic template model for studying antitubercular drug effects in vitro - O. Clewe

Pharmacokinetics of levofloxacin in M(X)DR tuberculosis patients - N. Van’t Boveneind- Vrubleuskaya

Pharmacological Knowledge Gaps in the Treatment of TB Meningitis - Guy Thwaites, MA, MBBS, PhD, FRCP, FRCPath, FMedSci

Inhaled Therapy for TB - Edward Nardell, MD

Intra cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis - R. Kempker

Anti-Tuberculosis Activity of Pyrazinamide Varies by Lesion Type in C3heb/Fej Mice - Lanoix, J.-P

Computational pharmacology of rifampin in mice: an application to dose optimization with conflicting objectives in tuberculosis treatment - M. Lyons

Real-time and non-invasive, multi-compartment pharmacokinetics of 11c-rifampin in mycobacterium tuberculosis infected mice using dynamic positron emission tomography - V.P. DeMarco